Trans Genic Inc. (2342.T)
JPY 181.0
(0.56%)
JPY 181.0
(0.56%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.22 Billion JPY | -0.47% |
| 2022 | 2.23 Billion JPY | 30.52% |
| 2021 | 1.71 Billion JPY | 31.01% |
| 2020 | 1.3 Billion JPY | 10.93% |
| 2019 | 1.18 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.49 Billion JPY | 12.04% |
| 2023 Q1 | 2.37 Billion JPY | 6.08% |
| 2023 Q4 | 2.22 Billion JPY | -14.1% |
| 2023 Q3 | 2.59 Billion JPY | -5.02% |
| 2023 Q2 | 2.73 Billion JPY | 14.99% |
| 2023 FY | 2.22 Billion JPY | -0.47% |
| 2022 Q4 | 2.23 Billion JPY | -7.41% |
| 2022 FY | 2.23 Billion JPY | 30.52% |
| 2022 Q3 | 2.41 Billion JPY | 4.91% |
| 2022 Q2 | 2.3 Billion JPY | 0.0% |
| 2021 FY | 1.71 Billion JPY | 31.01% |
| 2020 FY | 1.3 Billion JPY | 10.93% |
| 2019 FY | - JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | -226.159% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -12325.121% |
| GNI Group Ltd. | 2.33 Billion JPY | 4.416% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -3201.226% |
| Soiken Holdings Inc. | 1.12 Billion JPY | -98.748% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -2051.66% |
| AnGes, Inc. | 1.61 Billion JPY | -37.869% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -2910.446% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 23.262% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | -592.019% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -1210606.522% |
| Carna Biosciences, Inc. | 140.14 Million JPY | -1489.625% |
| CanBas Co., Ltd. | 728 Thousand JPY | -305902.747% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -2435.424% |
| RaQualia Pharma Inc. | 147.93 Million JPY | -1405.823% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -3374.972% |
| Kidswell Bio Corporation | 875.65 Million JPY | -154.404% |
| PeptiDream Inc. | 2.4 Billion JPY | 7.34% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -41601.61% |
| Ribomic Inc. | 2.27 Million JPY | -97863.94% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -222769999900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -6088.056% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -7581.724% |
| CellSource Co., Ltd. | 305.92 Million JPY | -628.185% |
| FunPep Company Limited | 25.54 Million JPY | -8622.055% |
| Kringle Pharma, Inc. | 364.05 Million JPY | -511.911% |
| Stella Pharma Corporation | 1.11 Billion JPY | -99.569% |
| TMS Co., Ltd. | 50.02 Million JPY | -4353.173% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -10558.342% |
| Cuorips Inc. | 1.04 Million JPY | -213485.81% |
| K Pharma,Inc. | 10.79 Million JPY | -20538.318% |
| Takara Bio Inc. | 11.85 Billion JPY | 81.201% |
| ReproCELL Incorporated | 248.14 Million JPY | -797.759% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | -394.4% |
| StemCell Institute Inc. | 42.26 Million JPY | -5171.166% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | -874.646% |
| CellSeed Inc. | 46.19 Million JPY | -4722.801% |